Chula Pharmaceutical Science helps increase public confidence to keep COVID-19 at bay with their new test kit to verify the safety and efficacy of hand sanitizers and alcohol-based gel and spray products.
As widely-anticipated decisions about COVID-19 vaccine boosters roll out from U.S. agencies today, insights from an independent study underscore why boosters are important for all adults.
Arguments over a complaint filed in the Circuit Court for the City of Norfolk, Virginia, were presented today to decide if patients of one of the world’s most published critical care physicians can be given lifesaving treatments for COVID-19 that a local hospital system has prohibited.
The current supply chain slowdown is wreaking havoc as we move into the holidays, causing shortages that will impact gift buying and what we put on the Thanksgiving table. There is not just one single issue or breakdown in the…
For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.
On top of the COVID-19 pandemic, people worldwide have dealt with an infodemic – a flood of ever-evolving information and misinformation about the virus, causing confusion and mistrust. New Cornell research finds that in remote parts of Bangladesh with little internet access, people have relied on local experts, spiritual views and their sense of social justice to evaluate new coronavirus information.
In an experiment to find an effective treatment for diabetic foot ulcers, which affect 62 million people worldwide, a team led by University of South Australia physicist Dr Endre Szili has made an unexpected discovery: the same technology kills the SARS-CoV-2 virus.
A new Cleveland Clinic study found that people with certain sleep disorders have more severe outcomes from COVID-19, including a 31 percent higher rate of hospitalization and mortality.
Researchers at Yale School of Medicine have discovered that an RNA molecule that stimulates the body’s early antiviral defense system can protect mice from a range of emerging SARS-CoV-2 variants. The study, published today in the Journal of Experimental Medicine (JEM), could lead to new treatments for COVID-19 in immunocompromised patients, as well as providing an inexpensive therapeutic option for developing countries that currently lack access to vaccines.
With conversations about COVID-19 vaccinations a likely centerpiece this holiday season, resources from the American Association of Critical-Care Nurses can help individuals prepare for potentially challenging discussions with family and friends who are hesitant about the vaccine.
Houston Methodist’s SARS-CoV-2 genome sequencing team has partnered on a study led by Penn State that revealed 80% of white-tailed deer sampled across Iowa at the height of the 2020-2021 deer-hunting season tested positive for the SARS-CoV-2 virus. Analysis of the virus genome sequences revealed infections were likely the result of multiple human-to-deer transmission “spillover” events followed by deer-to-deer transmission from April 2020 through January 2021.
As families prepare to gather later this month for Thanksgiving, it is important for patients who are immunocompromised to take extra steps to protect themselves from becoming infected with COVID-19. People who are immunocompromised have weakened immune systems, which means they have a higher risk of becoming severely ill from COVID-19.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have partnered with Horizon Blue Cross Blue Shield of New Jersey to launch a collaborative pilot program which provides oncology care to eligible patients in the comfort of their own home – the first of its kind in the state.
Université de Montréal chemists looked at lab samples of patients who recovered from a mild case of COVID-19 and found that those over 50 produced more antibodies against the SARS-CoV-2 virus.
UC San Diego scientists have created a new technology that rapidly detects the SARS-CoV-2 virus. The new SENSR was developed using CRISPR gene-editing technology as a rapid diagnostic that could eventually be used in homes, airports and other locations.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
Article title: Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia Authors: Mada Ghanem, Méline Homps-Legrand, Marc Garnier, Lise Morer, Tiphaine Goletto, Justine Frija-Masson, Paul-Henri Wicky, Pierre Jaquet, Catherine Bancal, Margarita Hurtado-Nedelec, Luc de Chaisemartin, Madeleine Jaillet, Arnaud…
A pandemia da COVID-19 tornou mais difícil para algumas pessoas praticarem seus exercícios diários. O comportamento sedentário, incluindo ficar sentado por longos períodos, pode contribuir para efeitos adversos à saúde, incluindo algo conhecido como “doença de ficar sentado.”
La pandemia de la COVID-19 provocó que a algunas personas les resulte más difícil realizar su entrenamiento diario. La conducta sedentaria, incluso estar sentado durante largos períodos, puede acarrear efectos adversos para la salud, que incluye lo que se conoce como “la enfermedad de estar sentado”.
As part of a recently launched international phase 3 clinical trial, Montefiore Health System and Albert Einstein College of Medicine are investigating whether the Merck antiviral pill, molnupiravir, now approved in Britain for treating COVID-19, can prevent COVID-19 in unvaccinated individuals living with people who have contracted the disease. Montefiore-Einstein is the first and only New York State site for the trial and was selected due to its diverse patient population and expertise in clinical trials of COVID-19 and other infectious diseases.
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive therapy appear to have an impaired immunity response to SARS-CoV-2, the coronavirus that causes COVID-19, vaccines. Patients currently on glucocorticoids or B-cell depleting therapy appear to have an even more severely impeded vaccine response.
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that in Alabama, one in 10 racial or ethnic minority patients with a rheumatic disease in a large rheumatology clinic said they were unlikely to get vaccinated against COVID-19.
The Morgridge Institute for Research will broadcast a free webinar on November 9, featuring a conversation with experts on the front lines of pediatric vaccine development and public health.
As we approach two full years of the COVID-19 pandemic, we now know it spreads primarily through airborne transmission. The virus rides inside tiny microscopic droplets or aerosol ejected from our mouths when we speak, shout, sing, cough, or sneeze. It then floats within the air, where it can be inhaled by and transmitted. This inspired researchers in India to explore how we can better understand and engineer airflow to mitigate the transmission of COVID-19.
Following FDA authorization of the COVID-19 vaccine for 5- to 11-year-olds, Together by St. Jude releases a free coloring book that educates children on COVID-19 vaccines.
The Department of Emergency Medicine at Hackensack University Medical Center has received a $352,000 grant from the New Jersey Department of Health to address Health Equity for COVID Prevention.
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows patients using rituximab were able to produce antibodies against COVID-19 after receiving a third vaccine dose, even if there was no development of the antibody after the first two.
The unfolded protein response plays a key role in how Middle East Respiratory Syndrome damages the lungs. MERS is much less common but much lethal than COVID-19, which is also caused by a coronavirus.
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.
Tulane psychologists are leading a project that aims to address pandemic-related issues among food service workers, including health and safety issues, stress and other long-term consequences.
As the Food and Drug Administration edges closer to emergency use approval of the Pfizer COVID-19 vaccine for children ages 5-11 – which could become available as soon as early November – Rutgers faculty and staff share reasons for why they’ll vaccinate their children.
Researchers published interim results in The New England Journal of Medicine from a Phase 3 study of the COVID-19 monoclonal antibody treatment sotrovimab, sponsored by Vir Biotechnology and GlaxoSmithKline. The study found that compared to the placebo group, COVID-19 patients who received sotrovimab had a significantly reduced risk of hospitalization or death and that the treatment, which was administered by intravenous infusion on an outpatient basis, was safe.
Research uncovers racial bias in oxygen readings during the COVID-19 pandemic, even amongst patients needing ECMO.
Three in 10 parents say they will “definitely not” get their 5- to 11-year-old vaccinated against COVID-19, according to new data from the Kaiser Family Foundation. Neil Lewis, Jr., a behavioral scientist at Cornell University who was not involved with…
When the COVID-19 pandemic walloped Oregon, its impact on its people and economic sectors varied wildly, and some of those effects could be long-lasting. While some counties saw unemployment rates soar above 20 percent, others remained solidly in the single…
Dr. Ishminder Kaur Dr. Kaur is an assistant professor of pediatrics in the division of infectious diseases at the David Geffen School of Medicine at UCLA and the medical director of the pediatric antimicrobial stewardship program at UCLA Mattel Children’s…
Since 1974, contaminated water has been the most common driver of large-scale zoonotic infectious disease outbreaks, according to new research from the Center for the Ecology of Infectious Diseases (CEID) at the University of Georgia.
Despite regional variations in COVID-19-related restrictions last year during the lockdown phase of the pandemic, similar trends emerged in activity at Level I trauma centers in four different cities from the Southeast to the Northwest.
Rutgers infectious disease expert Shobha Swaminathan is available to discuss the mixing and matching of COVID-19 vaccines and boosters as the Food and Drugs Administration authorized booster shots for both the Johnson & Johnson and Moderna vaccines. “There is mounting…
Researchers led by Jeffrey Skolnick have designed a new AI-based “decision prioritization tool” that combines data on protein pathways with common Covid-19 side effects and known patient comorbidities. The tool offers possible targeted treatment options with existing FDA-approved drugs to foster better health outcomes for individuals fighting Covid-19.
New research from Michigan State University reveals how political partisanship influenced schools’ reopening plans amid the global pandemic.
Chula physical therapy specialist invites seniors to exercise to boost their immunity against COVID-19 and stay fit even during home quarantine with easy ways to exercise at home during the lockdown.
Today SCIENION, a BICO company, announced it has entered into a strategic collaboration with diagnostic biotechnology company Pictor Limited to commercialize a high throughput SARS-CoV-2 antibody testing system. In the collaboration, the two companies will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test to create the only platform capable of testing both anti-nucleocapsid and anti-spike antibodies in one reaction. This analysis will be key to support the sustained fight against the pandemic by measuring the population’s level of herd immunity through natural infections and vaccinations.
Today, on World Lung Day (WLD), members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations, such as the American Thoracic Society, are calling for respiratory health to be a top priority in global decision-making beyond the COVID-19 pandemic.
Chula Pharmaceutical Science urges consumers to pay attention to “medicine labels” to choose and use green chiretta (Andrographis paniculata) effectively and safely. They also cautioned that the government should modify the labels, and control the price of herbal medicines that help in curbing the current pandemic.
Rutgers global health expert Richard Marlink, M.D., is available to discuss the importance of prioritizing vaccinations in low- to middle-income countries that need it the most, following President Biden’s pledge to donate an additional 500 million doses of the Pfizer-BioNTech COVID-19…
A new study finds that more access to daylight at home improves circadian alignment, sleep and mental health in healthy adults.
As public health leaders worldwide scramble to contain COVID-19’s delta variant, researchers at Michigan State University know what can provide early signs of the virus and help with critical decisions — sewage.
A newly published study found that women who contract COVID-19 during pregnancy are at significantly higher risk of developing pre-eclampsia, the leading cause of maternal and infant death worldwide.